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Prostaglandins sensitize sensory neurons to activation by 
mechanical, thermal and chemical stimuli. This sensitiza- 
tion also results in an increase in the stimulus-evoked re- 
lease of the neuroactive peptides, substance P and calci- 
tonin gene-related peptide from sensory neurons. The cel- 
lular transduction cascade underlying the prostaglandin- 
induced augmentation of peptide release is not known. 
Therefore, we examined whether the sensitizing action of 
prostaglandins on peptide release from sensory neurons 
grown in culture is mediated by the second messenger, 
adenosine 3’, 5’ cyclic monophosphate (CAMP). Prosta- 
glandin E, and carba prostacyclin (a stable analog of pros- 
taglandin I*) significantly increase the content of CAMP-like 
immunoreactive substance (icAMP) in the sensory neuron 
cultures at concentrations that also augment the bradyki- 
nin- or capsaicin-evoked release of peptides. Furthermore, 
pretreating sensory neurons with agents that increase in- 
tracellular CAMP mimics the sensitizing action of prosta- 
glandins. Exposing cultures to either forskolin (0.1-10 PM), 
cholera toxin (1.5 pg), or 8-bromo-CAMP (100 PM) results 
in a significant enhancement of the bradykinin- or capsa- 
icin-stimulated release of both substance P-like and calci- 
tonin gene-related peptide-like immunoreactive sub- 
stances. Pretreating sensory neurons with the adenylyl cy- 
clase inhibitor, 9-tetrahydro-2-fury1 adenine (5 mM), abol- 
ishes the prostaglandin-induced increases in icAMP 
content and attenuates the prostaglandin E, or carba pros- 
tacyclin enhancement of the evoked release of calcitonin 
gene-related peptide-like immunoreactive substance. 
These results demonstrate that the CAMP transduction cas- 
cade mediates the sensitizing actions of prostaglandins on 
peptide release from sensory neurons. 
[Key words: adenylyl cyclase, CAMP, calcitonin gene-re- 
lated peptide, dorsal root ganglia, prostaglandins, sensory 
neurons, substance P] 
Increasing evidence suggests that selective prostaglandins have 
a direct action on sensory neurons to enhance the release of 
neuroactive peptides, substance P (SP), and calcitonin gene-re- 
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lated peptide (CGRP). Indeed, micromolar concentrations of 
PGE, or PGI, increase peptide release from peripheral tissues 
(France-Cereceda, 1989; Geppetti et al., 1991), from spinal cord 
slices (Andreeva and Rang, 1993; Vasko et al., 1993), and from 
isolated sensory neurons (Nicol et al., 1992; Vasko et al., 1993). 
Recent studies in our laboratory have shown that nanomolar 
concentrations of PGE, or PGI, sensitize rat sensory neurons 
grown in culture, thereby augmenting the release of SP and 
CGRP evoked by the algogenic agents, capsaicin or bradykinin, 
without altering resting release (Hingtgen and Vasko, 1994a; 
Vasko et al., 1994). This effect of prostaglandins on peptide 
release is analogous to the sensitizing actions of these autocoids 
using other experimental end points. For example, pretreating 
sensory nerve preparations with PGE, or PGI, increases the 
number of action potentials elicited in response to thermal, me- 
chanical, or chemical stimuli (Handwerker, 1976; Mense, 1981; 
Baccaglini and Hogan, 1983; Martin et al., 1987; Schaible and 
Schmidt, 1988; Cui and Nicol, 1994). These prostanoids also 
reduce the intensity of noxious stimuli needed to elicit various 
escape behaviors in laboratory animals (Ferreira et al., 1978; 
Taiwo et al., 1987), and they enhance pain perception in man 
(Ferreira, 1972). Because the release of SP and CGRP from 
sensory neurons is a critical event in modulating pain perception 
and in initiating neurogenic inflammation (Cuello, 1987; Kura- 
ishi et al., 1988; Payan, 1989), it is interesting to speculate that 
prostaglandin-induced hyperalgesia may result from an action of 
these autocoids on peptide release. 
Although PGE, and PGI, can sensitize sensory neurons, en- 
hancing excitability and peptide release, the signal transduction 
cascade mediating these actions has not been elucidated. We 
therefore performed experiments to test the hypothesis that the 
sensitizing actions of prostaglandins on peptide release are me- 
diated by activation of the CAMP transduction cascade. This 
hypothesis is based in part on indirect evidence suggesting that 
the hyperalgesic actions of prostaglandins are mediated by 
CAMP (Ferreira and Nakamura, 1979; Taiwo et al., 1989; Taiwo 
and Levine, 199 1). Furthermore, in non-neuronal cells, the bind- 
ing of PGI, or PGE, to specific prostanoid receptors can result 
in activation of the CAMP transduction cascade (Smith et al., 
1987; Jaschonek et al.; 1988; Namba et al., 1993). Because the 
transduction cascade for various prostaglandins is tissue specific, 
it is necessary to establish cause-effect relationships between 
prostaglandin actions on sensory neurons and changes in CAMP 
to determine if prostaglandin-induced sensitization of sensory 
neurons is mediated by this second messenger. 
To establish if the sensitizing action of prostaglandins on pep- 
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tide release is mediated by activation of the CAMP transduction 
cascade, we studied the effects of manipulating this second mes- 
senger on the evoked release of SP-like and CGRP-like immu- 
noreactive substances (iSP; iCGRP) from rat sensory neurons in 
culture. We also examined the effects of inhibiting CAMP pro- 
duction in sensory neurons on the ability of prostaglandins to 
augment peptide release evoked by capsaicin or bradykinin. 
Our results demonstrate that pretreating sensory neurons in 
culture with agents that increase intracellular CAMP enhances 
the release of peptides evoked by either bradykinin or capsaicin 
in a manner analogous to PGE, or PGI,. Furthermore, preventing 
the prostaglandin-induced increase in intracellular CAMP atten- 
uates the sensitizing actions of these prostanoids on the evoked 
release of iCGRF! 
Preliminary findings from these studies have appeared in ab- 
stract form (Hingtgen and Vasko, 1992; Waite and Vasko, 1992). 
Materials and Methods 
Materials. Timed-pregnant Sprague-Dawley rats were obtained from 
Harlan-Sprague Dawley, Inc. (Indianapolis, IN). Cell culture supplies 
were purchased from GIBCO BRL (Grand Island, NY), and nerve 
growth factor from Harlan Bioproducts for Science, Inc. (Indianapolis, 
IN). Peptides were obtained from Peninsula Laboratory (Belmont, CA), 
prostaglandins from Caymen Chemical Co. (Ann Arbor, MI), and all 
other chemicals from Sigma Chemical Co. (St. Louis, MO). The ad- 
enylyl cyclase inhibitor, 9-(tetrahydro-2-furyI)adenine, was a generous 
gift from G. Nicol (Indiana University School of Medicine), who ob- 
tained the compound on request from Squibb Industries (Princeton, NJ). 
Prostaglandins, capsaicin, and forskolin were initially dissolved in 
1-methyl-2-pyrrolidinone (HPLC grade, Aldrich Chemical Company, 
Milwaukee,- WI) and then diluted- to appropriate concentrations- with 
HEPES buffer. This vehicle did not alter the release of either oeutide 
at the concentrations used. 
Isolation and culture of embryonic rat sensory neurons. The proce- 
dure for isolating and growing sensory neurons has been described pre- 
viously (Hingtgen and Vasko, 1994a; Vasko et al., 1994). The sensory 
neurons were dissociated from the dorsal root ganglia of E15-El7 rat 
embryos using 0.025% trypsin (type IX) and mechanical agitation. Ap- 
proximately 150,000 cells were plated into collagen-coated wells of a 
24-well Falcon culture dish and grown in Dulbecco’s Modified Eagle 
Medium supplemented with 2 mM glutamine, 50 kg/ml penicillin and 
streptomycin, 10% (v/v) heat-inactivated fetal bovine serum, 50 PM 
5-fluoro-2’-deoxyuridine, 150 PM uridine, and 250 rig/ml nerve growth 
factor. Cultures were maintained at 37°C in a 5% CO,, 95% air atmo- 
sphere. The medium was changed every second day. 
Release of BP and iCGRP from sensory neurons. After 9-12 d in 
culture, release studies were performed on the cells as previously de- 
scribed (Hingtgen and Vasko, 1994a; Vasko et al., 1994). Briefly, the 
neuronal cultures were washed once with HEPES buffer consisting of 
(in mM) 25 HEPES, 135 NaCl, 3.5 KCl, 2.5 CaCl,, 1 MgCl,, 3.3 D-glu- 
cose, 0.1 ascorbic acid, 0.02 bacitracin, 0.001 phosphorhimadon, and 
0.1% bovine serum albumin, pH 7.4 and maintained at 37”C, then in- 
cubated for successive 10 min intervals with 0.4 ml of the same buffer 
in the absence or presence of drugs. Basal or resting release was deter- 
mined by exposing the cells to HEPES buffer alone, or buffer in the 
presence of prostaglandins, forskolin, S-bromo adenosine 3’, 5’-cyclic 
monophosphate (8.bromo CAMP), cholera toxin, or 9-tetrahydro-2-fury1 
adenine (THFA). To determine evoked release, the initial incubation 
was followed by a 10 min incubation with the same concentration of a 
drug in the presence of 50 nM capsaicin or 100 nM bradykinin. We have 
previously demonstrated that these concentrations of capsaicin and bra- 
dykinin cause submaximal stimulation of peptide release (Hingtgen and 
Vasko, 1994a; Vasko et al., 1994). Consequently, the use of these con- 
centrations optimized the possibility of observing an enhancement or 
inhibition of evoked release by prostaglandins or agents that alter intra- 
cellular CAMP After exposure to the stimulus, cells were reexposed to 
HEPES buffer without drugs for one or two 10 min incubations to 
reestablish resting release. During incubations, the cells were main- 
tained in a 5% CO, environment at 37°C. When the cells were pretreated 
with 8-bromo CAMP, THFA, or cholera toxin, the drug was added to 
the culture medium for the designated pretreatment time, and then the 
cells were initially incubated in HEPES buffer containing the same con- 
centration of the agent to determine if the drug altered basal release. 
After each incubation, the buffer was removed to measure the amount 
of both iSP and iCGRP using radioimmunoassays (RIAs) as previously 
described (Vasko et al.. 1993. 1994). The antiserum for iSP was raised 
in our laboratory (Pang and Vasko: 1986), whereas the iCGRP antise- 
mm was a generous gift from Dr. M. Iadarola (NIH). At the highest 
concentrations utilized, none of the drugs used in these studies except 
THFA altered the RIAs for either peptide. THFA (5 mM) caused some 
interference with the iSP assay but did not affect the RIA for iCGRl? 
Consequently, iSP release was not measured in experiments involving 
THFA. 
Determination of icAMP content in sensory neuronal cultures. The 
content of CAMP-like immunoreactive substance (icAMP) was mea- 
sured from cells after 9-12 d in culture. Growth medium was aspirated 
from the culture dish and cells were washed with 0.5 ml of HEPES 
buffer containing 2 mM 3-isobutyl- I-methyl-xanthine (IBMX, a phos- 
phodiesterase inhibitor). After washing, cells were incubated in 0.5 ml 
HEPES containing IBMX for 20-30 min in the absence or presence of 
other drugs. In the absence of IBMX, tissue content of icAMP under 
control conditions was at or near the limit of delectability of the radio- 
immunoassay. Consequently, IBMX was used in all experiments to en- 
hance the content of CAMP in the cultures and thus allow statistical 
comparison of “basal” levels of the nucleotide with the effects of pros- 
taglandins and forskolin. The HEPES buffer was aspirated and the cells 
were exposed to 100 mM HCl. The cells were scraped into the acid 
solution and these samples were removed, boiled for 5 min, and cen- 
trifuged at 1200 X g for 15 min. The supernatant was frozen and ly- 
ophilized. Samples were resuspended and assayed with a CAMP assay 
kit (NEN Products, DuPont Co., Wilmington, DE) using the nonacetyl- 
ated protocol. 
Statistical analysis. Unless otherwise stated, data is presented as the 
mean + standard error of the mean (SEM) of wells from at least three 
separate experiments. To compare the effects of various concentrations 
of one drug or the effects of drug combinations, an overall test based 
on the analysis of variance was performed. If  this test indicated that a 
difference existed, post hoc tests were performed. To compare the effect 
of different concentrations of one compound to basal or vehicle levels, 
a Fisher’s LSD test was perfarmed. To compare several different treat- 
ments, a Bonferroni-Dunn all means test was used. The significance 
level for all tests was set at 0.05. 
Results 
Selected prostaglandins increase the content of icAA4P in 
sensory neuronal cultures 
As a first step in establishing that CAMP is involved in the sen- 
sitizing actions of prostaglandins on peptide release, we deter- 
mined whether PGE, or CPGI, could elevate the content of 
icAMP in the cultures. This was accomplished by exposing sen- 
sory neurons to various concentrations of these prostanoids for 
20-30 min in the presence of IBMX and directly measuring 
cyclic nucleotide content. When sensory neurons were incubated 
for 20 min with HEPES buffer containing 2 mM IBMX, the basal 
levels of icAMP were 4.8 + 0.3 pmol/well and 5.8 ? 1 .O pmoll 
well (open columns Fig. IA). Exposing the neurons to 10 nM 
PGE, did not increase icAMP content. In contrast, both 100 nM 
and 1 PM PGE, caused a significant increase in icAMP levels 
to 10.1 + 1 .I pmol/well and 12.6 ?Z 1.0 pmoVwel1 (n = 24), 
respectively (Fig. 1A). In a similar manner, treating the neuronal 
cultures for 30 min with various concentrations of CPGI, re- 
sulted in a significant increase in icAMP content compared to 
cultures treated with 2 tTIM IBMX alone. Both 1 nM and 10 nM 
CPGI, elevated icAMP levels approximately twofold compared 
to basal levels, whereas higher concentrations (100 nM or 1 pM) 
increased content of the cyclic nucleotide by five- to sixfold 
(Fig. 1A). The observation that 100 nM PGE,, 1 p,M PGE,, ar 1 
nM CPGI, causes a twofold increase in icAMP content is par- 
ticularly interesting because these concentrations of prostanoids 
enhance the stimulus-evoked release of iSP and iCGRP without 
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Figure I. Content of icAMP in sensory neuronal cultures is increased after exposure to PGE,, CPGI,, or forskolin. The columns represent the 
mean + SEM of the amount of icAMP extracted from individual sensory neuron cultures in pmol/well. A, The open column shows icAMP formed 
when cells are exposed to HEPES buffer containing 2 mM IBMX without prostanoid treatment (BASAL). The shaded columns represent cells treated 
with buffer containing IBMX and various concentrations of PGE, for 20 min or various concentrations of CPGI, for 30 min. B, The open column 
shows CAMP formed when cultures are exposed to HEPES buffer containing 2 mM IBMX in the absence of forskolin (BASAL), whereas the hatched 
column represents icAMP content when cells were exposed to buffer containing IBMX and various concentrations forskolin for 20 min. An asterisk 
indicates significant differences from controls determined by analysis of variance and Bonferroni-Dunn all means test (JJ < 0.05). 
altering resting release (Hingtgen and Vasko, 1994a; Vasko et 
al., 1994). 
As a potential negative control, we examined the effects of 
prostaglandin F,, (PGF,,) on icAMP content. We chose this 
prostanoid, because we have previously demonstrated that 1 PM 
PGF,, does not alter the resting or stimulus-evoked release of 
iSP or iCGRP (Hingtgen and Vasko, 1994a; Vasko et al., 1994). 
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Figure 2. Forskolin augments bradykinin-stimulated release of iSP 
and iCGRP from rat sensory neurons. The ordinate represents the 
amount of iSP (open diamonds) and iCGRP (@led squares) release in 
cells exposed to HEPES buffer in the absence of bradykinin (BASAL) 
and release evoked by 100 nM bradykinin (BK) in the absence and 
presence of forskolin, expressed in fmol/well/lO min incubation period. 
Values are the mean + SEM of the amount of peptide released in 6- 
10 wells. Cells were treated with forskolin 20 min prior to and through- 
out the bradykinin stimulation. An asterisk indicates statistically signif- 
icant difference between release caused by bradykinin alone and by 
bradykinin in the presence of forskolin as determined by an analysis of 
variance and Fisher’s LSD @ < 0.05). 
Exposing neuronal cultures to this prostanoid for 30 min at con- 
centrations of 100 nM and 1 PM did not significantly increase 
the content of icAMP compared to untreated controls. The levels 
of icAMP in cultures treated with 100 nM or 1 PM PGF,, were 
5.0 ? 0.4 (n = 4) and 8.0 + 1.0 (n = 7) pmol/well, respec- 
tively. 
Agents that increase CAMP levels enhance stimulus-evoked 
peptide release 
To further investigate the role of CAMP in facilitation of peptide 
release, we tested whether elevating intracellular CAMP alters 
the resting or evoked release of iSP and iCGRP from isolated 
sensory neurons. To increase intracellular CAMP, cultures were 
pretreated with either forskolin, 8-bromo CAMP or cholera tox- 
in, then resting and evoked release of peptides was determined. 
When neurons in culture were exposed for 20 min to 0.1, 1, or 
10 p,M forskolin in the presence of 2 mM IBMX, there was a 
significant increase in icAMP content compared to cells treated 
with IBMX alone (Fig. 1B). This increase was concentration 
dependent in that the lowest concentration of forskolin tested 
increased icAMP levels approximately twofold from a basal val- 
ue of 4.7 % 0.3 to 9.4 ? 3.1 pmol/well (n = 7) whereas 1 FM 
and 10 FM forskolin elevated icAMP levels to 28.6 2 0.9 pmol/ 
well (n = 6) and 58.5 ? 5.0 pmol/well (n = 6) respectively 
(Fig. 1B). 
We next examined whether pretreating sensory neurons with 
forskolin would alter either the resting or evoked release of iSP 
or iCGRF! Sensory neurons in culture were exposed to various 
concentrations of forskolin for 20 min prior to and throughout 
a 10 min incubation with 100 nM bradykinin. In the absence of 
forskolin, the bradykinin-evoked release of iSP and iCGRP was 
42 ? 3 fmol/well/lO min and 134 ? 14 fmol/well/lO min, 
respectively (Fig. 2); a significant increase over basal release 
levels. The lowest concentration of forskolin tested (10 nM) did 
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not enhance the bradykinin-stimulated release of either iSP or 
iCGRP (Fig. 2). However, at concentrations of 100 nM to 10 
PM, forskolin pretreatment significantly augmented the bradyki- 
nin-evoked release of both iSP and iCGRP Exposing the neu- 
rons to 100 nM forskolin increased the bradykinin-evoked pep- 
tide release approximately 1 S-fold. Treating sensory neurons 
with 1 PM forskolin caused a 1.6-fold enhancement of iSP re- 
lease to a value of 68 + 13 fmol/well/lO min and a twofold 
augmentation of iCGRP release to a value of 278 ? 63 fmol/ 
well/l0 min compared to neurons exposed to 100 nM bradykinin 
alone (Fig. 2). In a similar manner, 10 pM forskolin increased 
bradykinin evoked release of iSP and iCGRP to 121 ? 16 and 
342 + 46 fmoVwell/ 10 min, respectively. In contrast to its 
effects on evoked release, treating cultures with forskolin alone 
(0.01-10 PM) had no effect on basal release of either peptide 
(data not shown). 
When neuronal cultures were exposed to 50 nM capsaicin, an 
agent that selectively activates small diameter sensory neurons 
(Holzer, 1991), there was a four- to fivefold increase in the re- 
lease of both iSP and iCGRP above basal levels (Fig. 3, left 
panels). Pretreating sensory neurons with 1 pM forskolin (a con- 
centration that had no effect on resting peptide release; hatched 
columns) significantly enhanced the capsaicin-stimulated release 
of both peptides compared to cells exposed to capsaicin alone. 
Release of iSP evoked by capsaicin alone was 32 + 9 fmol/ 
well/l0 min (n = 10 wells), whereas iCGRP release was 206 
+ 14 fmoVwelVl0 min (n = 9 wells). After forskolin, the cap- 
saicin-evoked release of iSP was increased eightfold to a value 
of 251 + 34 fmol/well/lO min, and the release of iCGRP was 
augmented sevenfold to 1355 2 258 fmol/well/lO min. Peptide 
release also was significantly elevated in the 10 min interval 
after exposure to capsaicin, but returned to resting levels in the 
subsequent 10 min incubation (data not shown). The increase in 
release during the 10 min after capsaicin exposure occurred in 
both control cells (left panels, Fig. 3) and forskolin-treated cells 
(right panel, Fig. 3), suggesting that the effect was secondary to 
capsaicin treatment and not because of an elevation in CAMP 
One limitation of the studies using forskolin is that this agent 
may have actions that are not specifically mediated by an in- 
crease in adenylyl cyclase activity (Laurenza et al., 1989). Con- 
sequently, we exposed sensory neurons to either 8-bromo CAMP 
or cholera toxin to elevate intracellular levels of CAMP and de- 
termined the effects on resting and bradykinin-evoked peptide 
release. Treating the sensory neurons with 100 pM 8-bromo 
CAMP (a membrane permeable analog of CAMP) for 60 min 
prior to and throughout the stimulus period, did not alter resting 
release of either peptide (hatched columns, Fig. 4), but caused 
an approximate twofold enhancement of the release evoked by 
100 nM bradykinin (Fig. 4). The bradykinin-evoked release of 
iSP was elevated from 45 & 3 fmol/well/lO min in cultures not 
treated with 8-bromo CAMP to 112 + 16 fmol/well/lO min (n 
= 15 wells) after the CAMP analog. In a similar manner, iCGRP 
release was augmented from 9 1 + 8 to 163 -+ 18 fmol/well/lO 
min. 
Exposing the cultures to a lower concentration of 8-bromo- 
CAMP (10 FM) did not alter either the resting or bradykinin- 
evoked release of either peptide. When sensory neurons were 
exposed to 100 nM bradykinin alone, release of iSP was 51 & 
4 fmol/well/lO min and iCGRP release was 124 ? 7 fmol/well/ 
10 min, whereas the bradykinin-stimulated release of iSP and 
iCGRP in the presence of 10 FM 8-bromo-CAMP was 54 + 4 
and 89 + 7 fmol/well/lO min for iSP and iCGRP, respectively. 
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Figure 3. Forskolin augments capsaicin-stimulated release of iSP and 
iCGRP from rat sensory neurons. The ordinates represent the amount 
of iSP (upper panel) or iCGRP (lower panel) released expressed in 
fmol/well/lO min incubation period. Each column represents the mean 
2 SEM of the amount of peptide released from 6-10 wells. Open 
columns represent the release of peptide when cells were exposed to 
HEPES buffer alone (BASAL); hatched columns represent release when 
cells were exposed to 1 pM forskolin (FOR), and-shaded columns in- 
dicate the release elicited by 50 nM capsaicin (CAP). In the panels on 
the right, cells were treated with 1 WM forskolin for 10 min prior to 
and throughout the capsaicin stimulation. An asterisk indicates a statis- 
tically significant difference from the initial basal release. A 7 indicates 
significant differences between capsaicin-evoked release in the absence 
and presence of forskolin. Both differences were determined by an anal- 
ysis of variance and Fisher’s LSD (? < 0.05). 
We also examined the effects of cholera toxin treatment on 
peptide release. For these studies, sensory neurons were exposed 
to 1.5 mg of cholera toxin for 16 hr; a treatment that ADP- 
ribosylates in excess of 95% of Gs (data not shown). As with 
the other manipulations to increase intracellular CAMP content, 
exposing sensory neurons to cholera toxin augmented the bra- 
dykinin-stimulated release of iSP and iCGRP (Fig. 5). The bra- 
dykinin-evoked release of iSP and iCGRP from sensory neurons 
not exposed to cholera toxin was 61 & 7 and 134 f  10 fmol/ 
well/l0 min (left panels, Fig. 5). In cultures pretreated with chol- 
era toxin release stimulated by bradykinin was increased ap- 
proximately twofold to 120 +- 3 fmol/well/lO min for iSP and 
to 293 ? 21 fmol/well/lO min for iCGRF! Resting or basal re- 
lease of the peptides was not affected by cholera toxin in the 10 
min incubation prior to bradykinin exposure (hatched columns, 
Fig. 5). Taken together, these data demonstrate that increasing 
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Figure 4. Bradykinin-stimulated release of iSP and iCGRP is en- 
hanced by treatment with 8bromo CAMP The columns represent the 
mean & SEM of the amount of iSP (upper panel) or iCGRP (lower 
panel) released in fmol/well/lO min incubation. Open columns show 
release when cells are exposed to HEPES buffer alone (BASAL; resting 
release), hatched columns represent peptide release after treatment for 
50 min with 100 pM 8-bromo CAMP (8.Br CAMP), and shaded columns 
release stimulated by 100 nM bradykinin (BK) alone (left panels) or in 
cultures pretreated for 1 hr with 100 FM 8-bromo CAMP (right panels). 
An asterisk indicates a statistically significant difference from the initial 
basal release. A t indicates significant differences between bradykinin- 
evoked release in the absence and presence of 8-bromo CAMP Both 
differences were determined by an analysis of variance and Fisher’s 
LSD (p < 0.05). 
intracellular levels of CAMP causes a facilitation of stimulus- 
evoked release of neuropeptides from rat sensory neurons. 
Inhibition of adenylyl cyclase abolishes prostaglandin- 
enhanced release of iCGRP 
To establish a causal relationship between the elevation of intra- 
cellular CAMP and prostaglandin-induced facilitation of peptide 
release, we determined the effect of pretreating sensory neurons 
with the adenylyl cyclase inhibitor, 9-tetrahydro-2-fury1 adenine 
(THFA; Goldsmith and Abrams, 1991) on peptide release. Cul- 
tures were treated with 5 mM THFA for 60 min prior to the 
beginning of the release experiment and treatment continued 
throughout exposure to either 100 nM bradykinin or 50 nM cap- 
saicin. As can be seen in Figure 6, exposing the neuronal cul- 
tures to 5 mM THFA abolished the increase in icAMP levels 
caused by either 100 nM PGE, or 1 nM CPGI,. As in previous 
experiments, when cultures were exposed to 2 mM IBMX then 
treated with prostaglandins, there was an approximate twofold 
increase in icAMP content. Basal levels of icAMP were 6.6 2 
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Figure 5. Bradykinin-stimulated release of iSP and iCGRP is en- 
hanced by treatment with cholera toxin. The columns represent the 
mean + SEM of the amount of iSP (upper panel) or iCGRP (lower 
panel) released in fmol/well/lO min incubation. Open columns show 
release when cells are exposed to HEPES buffer (BASAL; resting re- 
lease), hatched columns represent peptide release after treatment with 
1.5 mg cholera toxin (CTOX), and-shaded columns release stimulated 
by 100 nM bradykinin (BK) alone (left panels) or in cultures pretreated 
for 16 hr with 1.5 mg cholera toxin (right panels). An asterisk indicates 
a statistically significant difference from the initial basal release. A t 
indicates significant differences between bradykinin-evoked release in 
the absence and presence of cholera toxin. Both differences were de- 
termined by an analysis of variance and Fisher’s LSD @ < 0.05). 
0.4 pmol/well of neurons, whereas 100 nM PGE, or 1 nM CPGI, 
increased levels to 11.1 ? 0.8 or 11.2 + 2.0 pmol/well, re- 
spectively. When cultures were pretreated with 5 IIIM THFA, 
icAMP levels were 7.0 + 0.8 after PGE, and 6.0 ? 1.0 after 
CPGI,. 
Because 5 mM THFA abolished the prostaglandin-induced in- 
crease in icAMP content, we studied whether this inhibitor of 
adenylyl cyclase would affect the ability of PGE, or CPGI, to 
enhance the release of iCGRP evoked by bradykinin or capsa- 
icin. In these experiments, we only examined the effects on 
iCGRP release because 5 mM THFA interfered with the SP ra- 
dioimmunoassay. As shown in Figure 7A, exposing sensory neu- 
rons in culture to 100 nM bradykinin increases the release of 
iCGRP from a basal level of 149 ? 25 to 415 ? 83 fmol/well/ 
10 min. Pretreatment with 100 nM PGE, for 20 min significantly 
enhanced the bradykinin-stimulated release l.Cfold to a value 
of 600 ? 82 fmol/well/lO min (n = 8 wells). When cells were 
treated with 5 mM THFA, the PGE,-mediated enhancement of 
stimulated release was abolished (317 + 53 fmol/well 10 min). 
The adenylyl cyclase inhibitor did not alter the resting release 
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Figure 6. 9-Tetrahydro-2-fury1 adenine (THFA) inhibits the forma- 
tions of icAMP induced by prostaglandins in sensory neuronal cultures. 
The columns represent the mean -C SEM of the amount of icAMP 
extracted from individual sensory neuron cultures in pmol/well. The 
open column shows icAMP formed when cells are exposed to HEPES 
buffer containing 2 mM IBMX without additional drug treatment (BAS- 
AL). The shaded columns and the hatched columns represent cells treat- 
ed with buffer containing IBMX and either 100 nM PGE, for 20 min 
or 1 nM CPGI, for 30 min in the absence or presence of pretreatment 
with 5 mM THFA for 60 min prior to the addition of prostanoids. An 
asterisk indicates significant differences from controls determined by 
analysis of variance and determined by an analysis of variance and 
Fisher’s LSD (P < 0.05). 
of iCGRP; however, THFA significantly attenuated the bradyk- 
inin stimulated release to 222 2 30 fmol/well/lO min. 
9-Tetrahydro-2-fury1 adenine also abolished the CPGI,-me- 
diated enhancement of capsaicin-stimulated release (Fig. 7B). 
Exposing the neurons to 50 nM capsaicin caused a fourfold in- 
crease in iCGRP release from a resting level of 128 + 12 fmol/ 
well/l0 min to 542 rt 96 fmol/well/lO min. When cultures were 
pretreated with 1 nM CPGI, for 30 min, the capsaicin-stimulated 
release was facilitated twofold to 1009 2 210 fmol/well/lO min. 
In sensory neuronal cultures treated with 5 mM THFA, there 
was no significant inhibition of the capsaicin-evoked release of 
iCGRP, but the CPGI,-mediated facilitation of peptide release 
was abolished. Release in the presence of CPGI,, capsaicin, and 
THFA was reduced to 535 2 118 fmol/well/lO min. These re- 
sults demonstrate that increasing adenylyl cyclase activity and 
the resulting increase in CAMP are necessary for prostaglandin- 
induced facilitation of peptide release. 
Discussion 
The findings in this study establish that the CAMP transduction 
cascade mediates the prostaglandin-induced augmentation of 
peptide release from rat sensory neurons. Nanomolar concentra- 
tions of either PGE, or CPGI, significantly increase the content 
of icAMP in neuronal cultures. This profile of prostanoid action 
on icAMP parallels the effects of these autocoids on peptide 
release from isolated sensory neurons. Indeed, we have previ- 
ously demonstrated that the same concentrations of PGE, or 
CPGI, that increase icAMP content enhance iSP and iCGRP 
release evoked by either bradykinin, capsaicin, or high extra- 
cellular potassium (Hingtgen and Vasko, 1994a; Vasko et al., 
1994). In contrast, PGF,, does not facilitate evoked release of 
neuropeptides nor does it elevate the content of icAMP. 
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Figure 7. 9-Tetrahydro-2-fury1 adenine (THEA) inhibits prostaglan- 
din-induced enhancement of stimulus-evoked neuropeptide release. The 
ordinates represent the amount of iCGRP release expressed in fmol per 
well for each 10 min incubation period. Each column represents the 
mean ? SEM of the amount of peptide released from 7-14 wells. @en 
columns represent the release of peptide when cells were exposed to 
HEPES buffer alone (BASAL); hatched columns represent release when 
cells were exposed to 100 nM bradykinin (BK; upper panel) or 50 nM 
capsaicin (CAP; lower panel), and shaded columns indicate the release 
elicited by the stimuli after pretreatment with either 100 nM PGE, (up- 
per panel) or 1 nM CPGI, (lower panel). Where indicated, cells were 
exposed to 5 mM THFA 60 min prior to and throughout the stimulus 
exposure. An asterisk indicates a statistically significant difference be- 
tween treatments determined by an analysis of variance and Bonferroni- 
Dunn all means test 0, < 0.05). 
Increasing the content of CAMP in the neuronal cultures also 
enhances the evoked release of iSP and iCGRP in a manner 
analogous to that observed with prostaglandins (Hingtgen and 
Vasko, 1994a; Vasko et al., 1994). We used three different agents 
to increase CAMP in the cultures; forskolin, 8-bromo CAMP and 
cholera toxin. Forskolin directly activates adenylyl cyclase (Sea- 
mon and Daly, 1983) whereas 8-bromo CAMP is a membrane 
permeable and stable analog of CAMP (Miller et al., 1975), and 
cholera toxin activates the guanine nucleotide binding protein, 
Gs (Cassel and Selinger, 1977). Treating sensory neurons with 
any of these agents produces qualitatively similar effects on pep- 
tide release. In all instances, the activation of the CAMP trans- 
duction cascade sensitizes the sensory neurons, thereby aug- 
menting release evoked by stimulating agents without signifi- 
cantly altering resting release. Because these agents increase the 
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intracellular content of CAMP through separate mechanisms, it 
is highly unlikely that the facilitation of peptide release is the 
result of a nonspecific effect of any agent not related to elevation 
of CAMP 
Our results demonstrating that prostaglandin-sensitization is 
attenuated by inhibiting the activity of adenylyl cyclase estab- 
lishes a cause-effect relationship between actions of prostaglan- 
dins to increase CAMP levels and to enhance sensory neuron 
activity. Pretreating the sensory neurons in culture with the ad- 
enylyl cyclase inhibitor, THFA, abolishes the PGE, and CPGI,- 
induced increase in icAMP content. The same concentration of 
THFA also significantly reduces the prostaglandin-mediated ac- 
tions on the evoked release of iCGRP caused by two stimulating 
agents, bradykinin and capsaicin. These results, taken with the 
other findings discussed above, strongly support the conclusion 
that prostaglandins augment release through activation of the 
CAMP second-messenger system. 
Interestingly, exposing neuronal cultures to THFA not only 
attenuates the actions of prostaglandins but also significantly re- 
duces the bradykinin-evoked release of iCGRP This finding sug- 
gests that a component of the bradykinin-evoked release is me- 
diated by CAMP The actions of bradykinin on sensory neurons 
are thought to be mediated by activation of protein kinase C 
(Thayer et al., 1988; Burgess et al., 1989). Thus, it is possible 
that activation of PKC by bradykinin results in phosphorylation 
of isoforms of adenylyl cyclase, thereby increasing the produc- 
tion of CAMP. There is precedence for this type of “cross-talk” 
between second messengers. Phorbol esters activate PKC and 
this results in phosphorylation of various isoforms of adenylyl 
cyclase, thus increasing intracellular CAMP (Bell et al., 1985; 
Sibley et al., 1986; Jacobowitz et al., 1993). Whether the iso- 
enzymes of adenylyl cyclase that are substrates for PKC are 
present in sensory neurons is yet to be determined. 
It also is possible that bradykinin is increasing the production 
of endogenous prostaglandins in the neuronal cultures and these 
autocoids produce an increase in icAMP in sensory neurons and 
thus enhance release. Three lines of evidence support this pos- 
sibility. First, rat sensory neurons in culture are capable of syn- 
thesizing prostaglandins, predominately, PGE, (Vasko et al., 
1994). Second, the bradykinin-evoked release of iSP and iCGRP 
for isolated sensory neurons are partially blocked by indometh- 
acin, an inhibitor of PG synthesis, in a manner analogous to the 
effects of THFA (Vasko et al., 1994). Furthermore, other studies 
have shown that the stimulatory actions of bradykinin on sen- 
sory neurons are reduced in the presence of indomethacin 
(Griesbacher and Lembeck, 1987; Dray et al., 1992; Rueff and 
Dray, 1993). Finally, bradykinin stimulates the release of ara- 
chidonic acid from sensory neurons (Gammon et al., 1989) and 
increases the formation of prostaglandins in a number of tissues 
(McGiff et al., 1972; Lembeck et al., 1976; Allen et al., 1992). 
Our observation that CAMP mediates the facilitation of trans- 
mitter release in sensory neurons is consistent with findings in 
other neuronal preparations. For example, Kandel and co-work- 
ers showed that injection of CAMP or of the catalytic subunit of 
protein kinase A (PKA) into the sensory neuron of Aplysia, in- 
creases excitatory postsynaptic potentials (Castellucci et al., 
1980; Klein and Kandel, 1980). In addition, Andreeva and Rang 
(1993) observed a facilitation of electrically stimulated release 
of CGRP from rat spinal cord slices after exposure to forskolin 
or a phosphodiesterase inhibitor. 
The current results also substantiate the work of Ferreria and 
Nakamura (1979) and Taiwo and Levine (1991) that CAMP me- 
diates hyperalgesia and the sensitizing action of prostaglandins 
on paw withdrawal in response to a noxious stimulus. Indeed, 
an increase in the release of the neuropeptides SP and CGRP 
could be one mechanism to account for prostaglandin and 
CAMP-induced hyperalgesia. The current results, however, dis- 
agree with the conclusions of Kumazawa et al. (1993) that a 
decrease in intracellular CAMP rather than an increase, mediates 
prostaglandin sensitization of bradykinin activation of sensory 
neurons. They demonstrated that M&B28767, an agonist at the 
EP, receptor, mimics PGE,-induced enhancement of bradykinin- 
evoked discharges of the canine testis-spermatic nerve. This 
prostaglandin receptor is believed to be coupled to the G-protein, 
Gi, which inhibits adenylyl cyclase activity (Smith, 1992). They 
also observed that butaprost, an agonist at the EP, receptor (a 
receptor reported to be positively coupled to adenylyl cyclase 
activity (Honda et al., 1993), does not enhance the bradykinin- 
evoked response. This discrepancy between their conclusions 
and our work might be explained by the recent discovery of 
different subtypes of EP, receptors, that do not differ in agonist 
affinities, but couple to different G-proteins, including Gi and 
Gs (Namba et al., 1993). Thus, drug-induced activation of the 
EP, receptors on sensory neurons could increase or decrease the 
production of CAMP depending on the relative affinity of re- 
ceptor agonists and antagonists for the EP, receptor isoforms. 
It is likely that the prostaglandin activation of the adenylyl 
cyclase and the subsequent increase in CAMP will result in an 
increase in the phosphorylation of various proteins by PKA. 
Indeed, we have recently demonstrated that treating sensory neu- 
rons with the phosphatase inhibitor, okadaic acid, can sensitize 
these neurons to release evoked by bradykinin, capsaicin, or high 
extracellular potassium (Hingtgen and Vasko, 1994b). This ef- 
fect of okadaic acid on release is similar to that observed with 
PGE, and CPGI, and with an increase in intracellular icAMP, 
and suggests that enhanced protein phosphorylation may be a 
component of prostaglandin-induced sensitization. 
There are a number of substrates of protein phosphorylation 
that could account for the increase in peptide release. One pos- 
sibility is that PKA phosphorylates synaptic proteins that could 
alter the interaction of the vesicle with the cell membrane, thus 
allowing more peptide to be available for release upon stimu- 
lation. Although phosphorylation of synaptic proteins by PKA 
has not been demonstrated in mammalian sensory neurons, it 
has been observed in other neuronal systems (Levitan, 1988; 
Greengard et al., 1993). It is also possible that PKA directly 
phosphorylates ion channels, increasing the excitability of sen- 
sory neurons. Indeed, a number of studies have shown that both 
prostaglandins and CAMP facilitate the bradykinin and capsa- 
icin-induced excitation of sensory neurons (Handwerker, 1976; 
Martin et al., 1987; Dray et al., 1992; Rueff and Dray, 1993; 
Nicol and Cui, 1994). Furthermore, using patch-clamp tech- 
niques to record from isolated sensory neurons, Cui and Nicol 
(1994) recently demonstrated that PGE, pretreatment increases 
the number of action potential elicited by bradykinin and that 
this action is blocked by inhibition of PKA activity. Thus, the 
prostaglandin-induced increase in peptide release could result 
from increased excitability of sensory neurons presumably by 
affecting activity of ion channels. Indeed, PGE, and PGD, but 
not PGF,,, reduce the calcium-induced afterhyperpolarization of 
rabbit visceral sensory neurons (Weinreich and Wonderlin, 
1987). This afterhyperpolarization appears to be mediated by a 
potassium channel, and the effects of prostaglandins are mim- 
icked by forskolin. Similar results were reported by Grega and 
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MacDonald (1987) in mouse sensory neurons grown in culture. 
In addition, prostaglandins enhance calcium conductance in avi- 
an sensory neurons (Nicol et al., 1992), brain synaptosomes 
(Kandasamy and Hunt, 1990), and guinea-pig ventricular heart 
cells (Alloatti et al., 1991). 
The results presented here clearly demonstrate that prosta- 
glandin-induced facilitation of iSP and iCGRP release from sen- 
sory neurons is mediated by the adenylyl cyclase/cAMP trans- 
duction cascade. It remains to be determined whether specific 
cellular proteins are phosphorylated by activation of PKA and 
how this change in posttranslational processing affects neuro- 
peptide release from sensory neurons and the processes of pain 
signaling and neurogenic inflammation. 
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